Smart Cells

What Smart Cells does

Smart Cells International Ltd. is a UK-based private umbilical cord blood and tissue stem cell banking service, founded in 2001 as the country's first cord blood bank and currently operating as a subsidiary of FamiCord Group (parent: PBKM, Europe's largest stem cell bank network). The company collects, processes, and cryogenically stores neonatal stem cells at a purpose-built laboratory near London Heathrow Airport, using vapour phase nitrogen storage below -170°C and sterile processing aligned with European GMP Annex 1, NetCord-FACT, and JACIE standards under an HTA licence. Its core products are cord blood stem cell storage and cord tissue stem cell storage (mesenchymal cells from Wharton's jelly); an optional Neuro-Assistance Package coordinates potential autologous administration for children diagnosed with cerebral palsy or autism spectrum disorders.

The business model is direct-to-consumer, targeting expectant parents through educational content marketing, social media (Facebook, Instagram, LinkedIn, X, YouTube), email nurture, baby shows, and structured healthcare-professional referral partnerships with midwives, obstetricians, consultants, and 200+ NHS and private maternity hospitals across the UK. Revenue is generated via an upfront booking fee (starting at £325), a processing and storage fee due after the storage date, and either a recurring annual subscription (CPI-indexed) or a one-time prepaid multi-year plan; an Exit Fee applies for early termination within 10 years. Customers are acquired online, by phone, or in-hospital, and collection kits (e.g., the NanoCool temperature-monitored system) are dispatched for birthing-day retrieval.

As part of FamiCord Group, Smart Cells benefits from group-level scale (500,000+ families served, 1,000,000+ units stored, 240+ transplants, 7,500+ patients treated, 1,500+ collaborating hospitals across Europe). Disclosed UK leadership is limited: CEO Shamshad Ahmed and Scientific Director Dr Ann Smith are named, with no public executive bench beyond these roles. Revenue, funding history, and headcount beyond a stated 11–50 employee range are not publicly disclosed.

Name

Smart Cells

Legal name

Smart Cells International Ltd.

Website

https://smartcells.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

Smart Cells is a UK private umbilical cord blood and tissue stem cell bank serving expectant parents, cryogenically storing neonatal stem cells for potential future medical use as the UK arm of FamiCord Group.

Ownership category

akta.pro rank

Product category

Cord Blood Banking

NAICS

Blood and Organ Banks (621991)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

Keywords

• Umbilical cord blood banking
• Cord tissue storage
• Stem cell cryopreservation
• Newborn stem cells
• Family cord banking

Headquarters

HQ city

West Drayton

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Cord Blood Storage Services: Annual subscription or prepaid plans for umbilical cord blood and tissue stem cell storage services. Customers pay booking fees, processing fees, and recurring annual storage fees.
2. Cord Tissue Storage: Storage services for umbilical cord tissue containing mesenchymal stem cells from Wharton's jelly layer, offered as add-on to cord blood storage.
3. Neuro-Assistance Package: Optional coordination service for potential autologous administration of stem cells for children diagnosed with cerebral palsy or autism spectrum disorders.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels11 records

Core offering

Smart Cells collects, processes, and cryogenically stores umbilical cord blood and cord tissue stem cells from newborns for family-directed future therapeutic use. Customers purchase a collection kit, the kit is used at the birth by a trained phlebotomist, samples are couriered to Smart Cells' UK laboratory for processing and volume reduction, and the stem cells are stored in vapour-phase nitrogen below -170°C for up to 50 years. Optional add-ons include the exclusive Neuro package (providing access to Duke University cerebral palsy trials) and RNA/DNA extraction.

Product overview

Smart Cells is a private cord blood and tissue stem cell banking service, part of the FamiCord Group (Europe's largest stem cell bank). The core offering consists of umbilical cord blood stem cell storage and cord tissue stem cell storage services. The company processes and cryogenically stores samples at a facility near London Heathrow. Optional add-on services include the Neuro-Assistance Package for potential experimental treatments of cerebral palsy or autism, a Collection Kit with temperature-monitored transit, a Refer a Friend referral program, and a free downloadable parent guide. Storage is available under Prepaid or Subscription payment plans.

Differentiator

Problem solved

Functional benefit

Products and services

• Cord Blood Stem Cell Storage Long-term storage of umbilical cord blood stem cells for expectant parents in the UK. The service includes a collection kit, professional collection at birth, courier transport, volume-reduction processing in a UK lab, and continuous cryogenic storage.
• Cord Tissue Stem Cell Storage Storage of stem cells extracted from umbilical cord tissue (Wharton's jelly), capturing mesenchymal cells with regenerative medicine applications. Kit, processing and long-term storage are included.
• Neuro Package Exclusive optional add-on to Smart Cells' storage services that provides enrolled children with access to Duke University's umbilical cord clinical trials for conditions such as cerebral palsy.
• Umbilical Cord Collection Collection and storage of the entire umbilical cord for stem cell extraction, separate from cord blood and cord tissue offerings.
• RNA and DNA Extraction Optional service extracting RNA and DNA from stored cord tissue samples for future genetic or diagnostic use.

Quantifiable outcome

• Stem cells can treat up to 80 severe diseases including blood cancers, bone marrow disorders, immune deficiencies, and genetic disorders
• +2 more outcomes

Named customers4 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• FamiCord GroupcoreStrategic or Co-development PartnerSmart Cells is part of the FamiCord Group, Europe's largest stem cell bank serving 500,000+ families. The group operates across multiple European countries with shared resources, technology, and expertise in cord blood and tissue banking.
• PBKM (Polski Bank Komorek Macierzystych)coreStrategic or Co-development PartnerPBKM is the parent company of FamiCord Group and a leading provider of mesenchymal stem cells from cord tissue Wharton’s jelly. By March 2021, PBKM had supplied MSCs for treatment of 1687 patients on registered clinical trials.
• UK Hospitals (200+ NHS and Private)coreChannel Partner/ Reseller/ DistributorSmart Cells provides cord blood and tissue stem cell collection services across over 200 NHS hospitals and private maternity hospitals in the UK, including major London private maternity units.

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Cells4Life: UK-based private umbilical cord blood and tissue stem cell bank offering comparable consumer cord blood and cord tissue storage services, with overlapping NHS and private maternity hospital coverage. The most direct UK competitor to Smart Cells on product, customer, and channel.
• Future Health Biobank: UK-based private stem cell bank storing cord blood, cord tissue, and dental pulp stem cells, with multi-country European operations. Directly comparable DTC cord blood banking proposition aimed at expectant parents in the UK and Europe.
• Virgin Health Bank: UK-based private umbilical cord blood stem cell bank, one of the longest-established UK entrants. Competes head-to-head with Smart Cells for the same expectant parent segment in the UK, with similar collection-and-storage value proposition.

Broad incumbents

• Cryo-Cell International: US-listed (public) cord blood bank and one of the world's largest private family cord blood banks. Comparable consumer cord blood and tissue storage services with a longer public-company operating history and broader international footprint than Smart Cells.
• ViaCord: US-based private cord blood and cord tissue banking service (part of Revvity/PerkinElmer group). Offers the same expectant-parent DTC cord blood and tissue storage proposition as Smart Cells, with broader corporate parentage and US scale.
• Cord Blood Registry (CBR): Largest US private family cord blood bank, with over 1 million stored samples, serving the same expectant-parent use case as Smart Cells. Operates at significantly greater scale in North America and is a benchmark global incumbent in private cord blood banking.

Others

• PBKM (Polski Bank Komórek Macierzystych): Polish parent company of FamiCord Group and direct corporate parent of Smart Cells. Operates cord blood and MSC banking services across Poland and Europe; included as the upstream parent and source of MSC clinical pipeline rather than as a direct market competitor in the UK.

Emerging players

• Sevibe Cells: Spain-based FamiCord Group affiliate offering private cord blood and tissue storage across Iberia. Comparable product set to Smart Cells but primarily serving Spanish and Portuguese markets, representing a sister-brand rather than UK head-to-head competitor.
• Precious Cells International: UK-based private stem cell bank offering cord blood and tissue storage to expectant parents. Smaller and more niche than Smart Cells, but operates in the same UK DTC market and competes for the same hospital distribution and consumer demand.

Regional players

• Crioestaminal: Portugal-based private cord blood bank, also part of the FamiCord Group network. Offers directly comparable cord blood and tissue storage services to Smart Cells but is geographically focused on Portugal and selected Lusophone markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/smartcells
• YouTubeyoutube.com/c/smartcells
• Facebookfacebook.com/smartcellsofficial
• LinkedInlinkedin.com/company/smart-cells-international
• Instagraminstagram.com/smartcellsofficial

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Smart Cells